Home | Symbol Index | About |
Amb Generali Hldg (AMB)
Amb Generali Hldg is related to 2 other symbols. To date we've encountered 13 releases involving Amb Generali Hldg.
Last Price: 97.50 (0.00) - N/A,
N/A
- Open: N/A
- High: N/A
- Low: N/A
Amb Generali Hldg Options
Amb Generali Hldg "Business Partners"
A "business partner" is defined as a third party company that has co-released at least one press release with Amb Generali Hldg.
^
Amb Generali Hldg Press Releases
- Ambrilia Biopharma Inc.: Ambrilia Announces Positive Results of a Pivotal Human Pharmacokinetic Study of its New Prolonged Release Formulation of Octreotide (Trackbacks) (Backlinks), Thu, 26 Oct 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today positive results of a pivotal pharmacokinetic (PK) study of its lead specialty generic, Octreotide, for the treatment of acromegaly.
- Ambrilia Biopharma Inc.: Ambrilia Announces Share Consolidation (Trackbacks) (Backlinks), Wed, 18 Oct 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE)
- Ambrilia Biopharma Inc.: Ambrilia to Present at BIO Investor Forum in San Francisco (Trackbacks) (Backlinks), Tue, 17 Oct 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE)
- Ambrilia Biopharma Inc.: Ambrilia Biopharma and Merck & Co., Inc. Sign Licensing Agreement Granting Merck Worldwide Rights to Ambrilia's HIV/AIDS Protease Inhibitor Program (Trackbacks) (Backlinks), Thu, 12 Oct 2006 4:45:00 PDT
MONTREAL, CANADA and WHITEHOUSE STATION, NEW JERSEY (MARKET WIRE)
- Ambrilia Biopharma Inc.: Ambrilia to Present at Biocontact Quebec 2006 (Trackbacks) (Backlinks), Thu, 28 Sep 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE)
- Ambrilia Biopharma inc.: Ambrilia Presents Lead HIV Drug PPL-100 Data at the ICAAC 2006 (Trackbacks) (Backlinks), Wed, 27 Sep 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE)
- Ambrilia Biopharma Inc.: Ambrilia to Present at UBS Global Life Sciences Conference in New-York (Trackbacks) (Backlinks), Tue, 19 Sep 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS
- Ambrilia Biopharma Inc.: Ambrilia Highlights Positive Phase 1A Results For its Lead HIV Protease Inhibitor PPL-100 and Latest Developments in its Product Portfolio at Annual Meeting (Trackbacks) (Backlinks), Tue, 20 Jun 2006 8:02:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) At its Annual
- Ambrilia Biopharma Inc.: Ambrilia Reports Positive Phase Ia Results for its Lead HIV/AIDS Protease Inhibitor PPL-100 (Trackbacks) (Backlinks), Thu, 15 Jun 2006 5:07:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS
- Ambrilia Biopharma Inc.: Ambrilia Presents Data Showing High Genetic Barrier to its Lead HIV Inhibitor PPl-100 at the 15th International HIV Drug Resistance Workshop (Trackbacks) (Backlinks), Wed, 14 Jun 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, presented today a scientific poster reporting on the high genetic barrier and favorable cross-resistance profile of its lead HIV protease inhibitor (PI) PPL-100 at the 15th International HIV Drug Resistance Workshop, in Sitges, Spain.
^
Amb Generali Hldg News
- We have not detected any news yet.
^
Amb Generali Hldg Contact
^
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.